Tenaya Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for TNYA, updated each market day.
TNYA AI Sentiment
AI sees no strong directional signal for Tenaya Therapeutics, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Tenaya Therapeutics, Inc. Common Stock
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Sector
Exchange
Market Cap
$160,579,168
Cap Tier
Employees
70
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
July 30, 2021
TNYA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
TNYA Volatility
Tenaya Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
